Testosterone Patch May Treat Diabetes While Boosting Libido

Some diabetic men are being definite testosterone fit diabetes treatment, less than ritual drugs. The get going comes after a mug up published in 2009 suggests that up to 40 percent of men who experience Type 2 diabetes beget dismal testosterone levels. In this article from the Daily Mail, one pertinacious describes how testosterone gel helped benefit his blood sugar levels, determination levels, and his libido.

  • Share/Bookmark

Increased Risk Of Cardiovascular Problems In Depressed Men With Erectile Dysfunction

A renewed retreat in the Journal of Sexual Medicine establish that the sophistication of depressive sympto ms in men with erectile dysfunction constitutes a jeopardy factor for a major cardiovascular issue.

Erectile dysfunction and depressive keen are oft associated, and both are associated with an increased gamble of cardiovascular disorder and expiration. To examine clinical correlates moreover, researchers led in the main Elisa Bandini of the University of Florence well-thought-out take 2,000 masculine patients in a clinic in the service of lustful dysfunction using a structured appraise while also scoring destined for depressive symptoms.

Results reveal that in these subjects with erecti le dysfunction, depression increases cardiovascular problems independ ently from other known chance factors. Furthermore, even the treatment of antidepressant medications did not vary the relationship between severe depressive symptoms and adverse cardiovascular events.

“Recognizing depressive symptoms in subjects with erectil e dysfunction is mandatory not contrariwise for improving their sexual flair, but also object of preventing cardiovascular diseases,” Bandini notes.

“What is prominent take this scrutinize is the broader concept of the sexy nostrum unruly no longer being just round a man’s portrayal in the bedroom, but regarding his s piritual frame of mind and his cardiovascular healthiness,” states Irwin Goldstein, Editor-in-Chief of the Journal of Sexual Medicine and manager of sensuous pharmaceutical at Alvarado Hospital in San Diego. “This is a valid deduce to a woman to support her partaker to seek counter an eye to his erectile dysfunction.”

Source:
Amy Molnar
Wiley-Blackwell

  • Share/Bookmark

Link Between Statins, ED is Controversial

Two studi es may shed window on the effects cholesterol-lowering statins have on sex vigour. One Italian deliberate over appears to intimate that men with ED who take statins have diminish testosterone levels than their peers–but the element between the two factors is controversial. In as a matter of actual fact, American researchers who conducted a like study on a larger population found that long-term wear and tear of statins was associated with a reduce number of ED. These researchers chance the Italian research could designate that statins absolutely reduce the gamble of ED, but all of the researchers harmonize that help mull over is needed.

  • Share/Bookmark

Atlas Sexual Enhancement Products Recalled

The U.S. Food and Drug Administration is reporting a unconstrained cancellation of a all the way contrast of voluptuous enhancement products made large Atlas Operations Inc. The f ellowship has recalled the products after an judgement showed the products contained sulfoaildenafil, an add to like to sildenafil, an FDA-approved drug worn as treatment suited for erectile dysfunction. This ingredient is not listed on the products’ labels, and its deportment in the supplements makes them unapproved drugs. For a performed list of products convoluted in this disavowal, click on the link beneath.

  • Share/Bookmark

Federal Agents Seize FastSize Extenders And FastSize EQM Erectile Quality Monitors

At the petition of the U.S. Food and Drug Administration, U.S. Marshals seized $346,954.43 good of FastSize Extender devices and FastSize EQM Erectile Quality Monitor devices, as admirably as c omponent parts cast-off in the manufacture of the FastSize Extender. The FastSize Extender and the FastSize EQM Erectile Quality Monitor are manufactured and distributed about FastSize, LLC of Aliso Viejo, Calif.

The FastSize Extender and the FastSize EQM Erectile Qu ality Monitor are misbranded and adulterated because they, centre of other things, are unapproved and were man ufactured below conditions that did not upon bruited about Good Manufacturing Practices (cGMP) requirements. The confiscation permit was issued sooner than the U.S. District Court in return the Central District of California.

The FastSize EQM Erectile Quality Monitor crest was promoted to canon penile axial propriety (intercavernosal coercion and to subsidy in the diagnosis of trim agnate issues such as diabetes, tainted blood apply pressure on, and nucleus bug. The FastSize Extender machinery was promoted to profit ul timately, cummerbund, and blanket penile condition upswing and to dignified penile deformity caused by Peyronie’s cancer. Because the devices are in tended to diagnosis, remedy, blunt, freebie behaviour towards or inhibit diseases, they are source to the regulatory establishment of the FDA. The devices do not would rather approved applications championing premarket okay for these uses.

During a brand-new inspection of the FastSize LLC manufacturing proficiency, inspectors eminent valued deviations from cGMP corpus juris. Additionally, the devices are not well listed with the FDA as required in particular law, and the outfit failed or refused to fit out materials or low-down with regard to the devices to federal inspectors as required beneath the waves the Medical Device Reporting adjustment.

Source:
U.S. Food and Drug Administration

  • Share/Bookmark

Incontinence, ED Studies Often Leave Out Bad News: Report

Many studies published forth incontinence, erectile dysfunction and other urology subjects gloss all through the side effects, a new despatch suggests. Researchers about that enclosing 20 percent of studies don’t mention the reasons why think over participants dump in view of the library, or name other harmful effects of potential treatment. The disclose finds that discussing the bad advice would allow pati ents and doctors a more balanced feature of assessing whether a treatment is just suited for them.

  • Share/Bookmark

Study: Insurance Companies Invest Billions in Fast Food

Researchers at Harvard Medical School weight 11 mostly health-insurance companies hold billions of dollars importance of have in the fixedly aliment work. Companies such as Northwest Mutual, Prudential Financial, and Massachusetts Mutual own millions in trade in of Burger King, McDonalds, Taco Bell, the researchers organize. The study’s author–writing in the American Journa l of Public Health–say there is a “potency unhitch” between the aim of these condition guaranty companies and their investment in such debilitated businesses.

  • Share/Bookmark

Physician-Scientists Present At 2010 American Urological Meeting

Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center presented their latest enquire findings at the American Urological Association’s Annual Meeting in San Franci sco, May 29 to June 3.

Dr. Steven Kaplan, a urologist and professor of urology at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and Dr. Darracott Vaughan, chief maker and professor emeritus of urology at Weill Cornell Medical College, prepare published materials showing that 5-alpha reductase inhibitors (5-ARI), drugs occupied to charge payment genial prostatic hypertrophy (BPH), an enlarged prostate, may greatly fix up the correctness of unwritten PSA tests owing prostate cancer diagnosis.

“Taking 5-ARI drugs may upper-class the out of the limelight ballyhoo associated with PSA testing — canceling in default a non-virulent feedback and leaving simply ever ybody signal to malignancy,” explains Dr. Kaplan, outdo creator of the lessons. “Using PSA testing, we may sometimes be expert to feel prostate cancer from harmless prostatic hyperplasia (BPH) murrain.”

Dr. Kaplan presented these potentially groundbreaking findings during a flock briefing on June 1 and to go to convocation attendees on June 2.

Among the most imp ortant presentations are the following.Surgeons’ robotic surgery be familiar with has colliding on surgical cancer margins and operative time after time [2023]

Dr. Ashutosh Tewari
Director of Robotic Prostatectomy and Prostate Cancer-Urologic Oncology Outcomes and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

Dr. Tewari presented results from a multi-institutional den examining surgeons’ robotic surgical involvem ent. Recent media reports clothed raised concerns in any case training appropriate for robotic surgical procedures. The results of observation is outlined in this con, demonstrating that greater surgical test appears to be associated with a reduced portion of out-and-out surgical cancer margins and operative meanwhile after robot-assisted anarchist prostate removal.Generic envision of prostate enlargement benumb shows fewer side effects [1786]

Dr. Alexis Te
Director of the Brady Prostate Center and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Professor of Urology at Weill Cornell Medical College

Dr. Te presented results from a five-year swatting showing that generic, less-expensive dope inasmuch as controlling prostate enlargement may start fewer side-effects, such as erectile dysfunction, ejaculatory dysfunction, lowered libido and soul enlargement. The drugs 5-alpha reductase inhibitors (5-ARI) from been largely tolerant of in the executives of men with warm prostatic hypertrophy (BPH). The memorize compared the generic finasteride and designate stigmatize dutasteride. Fewer complications with laparoscopic kidney surgery compared with unstop [1482]

Dr. Douglas Scherr
Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center; Associate Professor of Urology at Weill Cornell Medic al College

Dr. Scherr presented results showing that laparosc opic surgery has fewer complications than conventional unsealed procedures conducive to the treatment of kidney disability and cancer, such as lowered operative ease during laparoscopic feeling an attraction nephrectomy (LPN), less blood wasting and shortened clinic stay.New su rgical modification exchange for reduced incontinence following prostate shifting [2029] Wednesday, June 2

Dr. Ashutosh Tewari
Director of Robo tic Prostatectomy and Prostate Cancer-Urologic Oncolo gy Outcomes and Urologist at NewYork-Presbyterian Hospital/Weill Cornell Medic al Center; Professor of Urology at Weill Cornell Medical College

Dr. Tewari presented findings sh owing that a surgical modification called the anatomic retro-apical system reduces incontinence following robotic prosta te slaughter surgery. Incontinence is the most familiar side execute followin g prostate removal.Source:
Andrew Klein
New York- Presbyterian Hospital/Columbia University Medical Center

View st upefy communication on dutasteride.

  • Share/Bookmark

Peyronie’s Disease

As the channel for semen and urine, the penis serves two important functions in men. But a disease described as early as the mid-18th century by a French physician, Francois Gigot de la Peyronie, which causes hardened patches on the penile shaft, can severely impact a man’s sexual performance. If you have pain and penile curvature characteristic of Peyronie’s disease, the following information should help you understand your condition.

What happens under normal conditions?

The penis is a cylindrical organ consisting of three chambers: paired corpora cavernosa (Two cylinder-shaped bodies that lie side by side in the penis and that, when filled with blood, enlarge to cause the penis to swell and become erect.) that are surrounded by a protective tunica albuginea (The hard covering that covers the testicle.); a dense, elastic membrane or sheath (A tubular covering that protects some body parts.) under the skin; and the corpus spongiosum (A column of erectile tissue in the center of the penis and surrounding the urethra. When filled with blood it enlarges and causes the penis to swell and become erect.), a singular channel, located centrally beneath and surrounded by a thinner connective tissue sheath. It contains the urethra, the narrow tube that carries urine and semen out of the body.

These three chambers are made up of highly specialized, sponge-like erectile tissue filled with thousands of venous cavities, spaces that remain relatively empty of blood when the penis is soft. But during erection, blood fills the cavities, causing the corpora cavernosa to balloon and push against the tunica albuginea. While the penis hardens and stretches, the skin remains loose and elastic to accommodate the changes.

What is Peyronie’s disease?

Peyronie’s disease (also known as fibrous cavernositis) is an acquired inflammatory (Characterized or caused by swelling, redness, heat and/or pain produced in an area of the body as a result of irritation, injury or infection.) condition of the penis.  It is the formation of a plaque or hardened scar tissue beneath the skin of the penis. This scarring is non-cancerous, but often leads to painful erection and curvature of the erect penis (a “crooked penis”).

What are the symptoms of Peyronie’s disease?

This scarring, or plaque, typically develops on the upper side of the penis (dorsum). It reduces the elasticity of the tunica albuginea (The hard covering that covers the testicle.) in that area and, as a result, causes the penis to bend upward during an erection. Although Peyronie’s plaque is most commonly located on the top of the penis, it may occur on the underside or on the lateral side of the penis, causing a downward or lateral bend.  Some patients may even develop a plaque that goes all the way around the penis, causing a “waisting” or “bottleneck” deformity of the penile shaft. The majority of patients complain of generalized shrinkage or shortening of their penis.

Painful erections and difficulty with intercourse usually lead men with Peyronie’s disease to seek medical help. Since there is great variability in this condition, sufferers may complain of any combination of symptoms: Penile curvature, obvious penile plaques, painful erection and diminished ability to achieve an erection.

Any of those physical deformities make Peyronie’s disease a quality-of-life issue. Not surprising, it is linked to erectile dysfunction in 20 to 40 percent of sufferers. While studies have shown that 77 percent of men demonstrate significant psychological effects, the numbers, medical researchers believe, are under reported. Instead, many men affected with this truly devastating condition suffer in silence.

How frequently does Peyronie’s disease occur?

Peyronie’s disease affects a reported one to 3.7 percent  (about one to four in 100) of males between ages 40 and 70, even though severe cases have been reported in younger men. Medical researchers believe the actual prevalence may be higher due to patient embarrassment and limited reporting by physicians. Since the introduction of sildenafil citrate, an oral therapy for impotence, doctors have reported increased incidence of Peyronie’s cases. With more men being treated successfully for erectile dysfunction in the future, an increasing number of cases presenting to urologists are anticipated.

What causes Peyronie’s disease?

Ever since Francois Gigot de la Peyronie, personal physician to King Louis XV, first reported penile curvature in 1743, scientists have been mystified by the causes of this well-recognized disorder. Yet medical researchers have speculated on a variety of factors that might be at work.

Most experts believe that acute or short-term cases of Peyronie’s disease are likely the consequence of a minor penile trauma, sometimes caused by sports injuries, but more often by vigorous sexual activity (e.g., the penis accidentally being jammed into a mattress). In injuring the tunica albuginea, that trauma triggers a cascade of inflammatory and cellular events resulting in the abnormal fibrosis (excess fibrous tissue), plaque and calcifications characteristic of this disease.

Such trauma, however, may not account for those Peyronie’s cases that begin slowly and become so severe that they require surgery. Researchers believe genetics or relationship with other connective tissue disorders may play a role. Studies already suggest that if you have a relative with Peyronie’s disease you have a greater risk of developing it yourself.

How is Peyronie’s disease diagnosed?

A physical examination is sufficient to diagnose curvature of the penis. The hard plaques can be felt with or without erection. It may be necessary to use injectable medications to induce an erection for proper evaluation of the penile curvature. The patient may also provide pictures of the erect penis for evaluation by the physician. Ultrasound of the penis may demonstrate the lesions in the penis but is not always necessary.

How is Peyronie’s disease treated?

Because Peyronie’s disease is a wound-healing disorder, changes are constantly occurring in the early stages. In fact, this disease can be classified into two stages: 1) an acute inflammatory phase persisting for six to 18 months during which men experience pain, slight penile curvature and nodule formations and 2) a chronic phase during which men develop a stable plaque, significant penile curvature and erectile dysfunction.

Occasionally the condition regresses spontaneously with symptoms resolving themselves. In fact, some studies show that approximately 13 percent of patients have complete resolution of their plaques within a year. There is no change in 40 percent of cases, with progression or worsening of symptoms in 40 to 45 percent. For these reasons, most physicians recommend a non-surgical approach for the first 12 months.

Conservative approaches:  Instead of requiring invasive diagnostic procedures or treatments, men who experience only small plaques, minimal penile curvature and no pain or sexual limitations, need only be reassured that the condition will not lead to malignancy or another chronic disease. Pharmaceutical agents have shown promise for early-stage disease but there are drawbacks. Because of a lack of controlled studies, scientists have yet to establish their true effectiveness. For instance:

  • Oral vitamin E: It remains a popular treatment for early-stage disease because of its mild side effects and low cost. While uncontrolled studies as far back as 1948 demonstrated decreases in penile curvature and plaque size, investigation continues concerning its effectiveness.
  • Potassium aminobenzoate: Recent controlled studies have shown that this B-complex substance popular in Central Europe yields some benefits. But it is somewhat expensive, requiring 24 pills each day for three to six months. It is also often associated with gastrointestinal issues, making compliance low.
  • Tamoxifen: This non-steroidal, antiestrogen medication has been used in the treatment of desmoid tumors, a condition with properties similar to Peyronie’s disease. Researchers claim that inflammation and the production of scar tissue are inhibited. But early-stage disease studies in England have found only marginal improvement with tamoxifen. Like other research in this area, however, these studies include few patients, and no controls, objective improvement measures or long-term follow up.
  • Colchicine: Another anti-inflammatory agent that decreases collagen development, colchicine has been shown to be slightly beneficial in a few small, uncontrolled studies. Unfortunately, up to 50 percent of patients develop gastrointestinal upset and must discontinue the drug early in treatment.

Injections:  Injecting a drug directly into the penile plaque is an attractive alternative to oral medications, which do not specifically target the lesion, or invasive surgical procedures, which carry the inherent risks of general anesthesia, bleeding and infection. Intralesional injection therapies introduce drugs directly into the plaque with a small needle after appropriate anesthesia. Because they offer a minimally invasive approach, these options are popular among men with either early phase disease or who are reluctant to have surgery. Yet their effectiveness is also under investigation. For instance:

  •  Verapamil: Early uncontrolled studies demonstrated that this substance interferes with calcium, a factor shown by in vitro cattle connective tissue cell studies to support collagen transport. As such, intralesional verapamil reduced penile pain and curvature while improving sexual function. Other studies have concluded that it is a reasonable treatment in men with non-calcified plaques and penile angles of less than 30 degrees.
  • Interferon: The use of these naturally-occurring antiviral, antiproliferative and anti-tumorigenic glycoproteins to treat Peyronie’s disease was born out of experiments demonstrating the antifibrotic effect on skin cells of two different disorders — keloids, overgrowth of collagenous scar tissue and scleroderma, a rare autoimmune disease affecting the body’s connective tissue. In addition to inhibiting proliferation of fibroblast cells, interferons, such as alpha-2b, also stimulate collagenase, which breaks down collagen and scar tissue. Several uncontrolled studies have demonstrated intralesional interferon’s effectiveness in reducing penile pain, curvature and plaque size while improving some sexual function. A current multi-institutional, placebo-controlled trial will hopefully answer many of the questions about intralesional therapy in the near future.

Other investigative therapies:  The medical literature is replete with reports on less invasive methods for treating Peyronie’s disease. But the effectiveness of treatments such as high-intensity focused ultrasound and radiation therapy, topical verapamil and iontophoresis, introducing soluble salt ions into the tissue via electric current, must still be investigated before these alternative therapies are considered clinically useful. Likewise, controlled studies using larger patient groups with longer follow ups are necessary to prove that the same high-energy shock waves used to break up kidney stones will have positive effects on Peyronie’s disease.

Surgery:  Surgery is reserved for men with severe disabling penile deformities that prevent satisfactory sexual intercourse. But, in most cases, it is not recommended for the first six to 12 months, until the plaque has stabilized. Since a spin-off of this disease is an abnormal blood supply to the penis, a vascular evaluation using vasoactive agents (drugs that cause erections by opening the vessels) is done prior to any surgery. A penile ultrasound if performed can also illustrate the anatomy of the deformity. The images allow the urologist to determine which patients are most likely to benefit from reconstructive procedures versus a penile prosthesis. The three surgical approaches include:

  • Nesbit procedure: First described to correct congenital penile curvature by cutting a portion of tissue from the tunica albuginea and shortening the unaffected side of the penis, this procedure is used by many surgeons today for Peyronie’s disease. Variations on the approach include the plication technique, where sutured tucks are placed into the side of maximum curvature to shorten and straighten the penis and the corporoplasty technique, where a longitudinal or lengthwise incision is closed transversely to correct the curvature. Nesbit and its variations are simple to perform and involve limited risk. They are most beneficial in men with ample penile length and lesser degrees of curvatures. But they are not recommended in individuals with short penises or severe curvatures as this procedure is recognized to shorten the penis somewhat.
  • Grafting procedures: defect with a When plaques are large and curvatures severe, the surgeon may choose to incise or cut out the hardened area and replace the tunicagraft material of some type. While the choice of materials depends on the doctor’s experience, preferences and what is available, some are more attractive than others. For instance:
    • Autograft tissue grafts: Taken from the patient’s body during surgery and thus less likely to cause an immunologic reaction, these materials usually require a second incision. They are also known to undergo postoperative contracture or tightening and scarring.
    • Synthetic inert substances: Materials such as Dacron® mesh or GORE-TEX® can cause significant fibrosis, a spreading of connective tissue cells. Occasionally palpated or felt by the patient, these grafts may cause more scarring.
    • Allografts or xenografts: Harvested human or animal tissues are the focus of most grafting material today These substances are uniformly strong, easy to work with and readily available because they are “off-the-shelf” in the operating room, so to speak. They act as scaffolds for the tunica albuginea tissue to grow over as the graft is naturally dissolved by the patient’s body.
  • Penile prostheses: A penile prosthesis may be the only good option for Peyronie’s disease patients with significant erectile dysfunction and insufficient blood vessels verified by ultrasound. In most cases, implanting such a device alone will straighten the penis, correcting its rigidity. But when that does not work, the surgeon may manually “model” the organ, bending it against the plaque to break the deformity, or the surgeon may need to remove the plaque over the prosthesis and apply a graft to completely straighten the penis.

What can be expected after treatment for Peyronie’s disease?

Routinely, a light pressure dressing is applied for 24 to 48 hours after the surgery to prevent any accumulation of blood. The Foley catheter is removed after the patient recovers from anesthesia and most patients are discharged later the same day or the following morning. During the healing process, medications to counteract erections are usually prescribed. The patient is also asked to take antibiotics for seven to 10 days postoperatively to ward off infection, and analgesics for any discomfort. If patients have no penile pain or other complications, they can resume sexual intercourse in six to eight weeks.

Frequently asked questions:

What happens to the cells following penile trauma?

In theory, following any penile trauma, there is a release of growth factors and cytokines or daughter cells that activate fibroblasts, cells that produce connective tissue. They, in turn, cause abnormal collagen deposition or scarring, which damages the internal elastic framework of the penis. Similar wound-healing disorders are commonly seen in the practice of dermatology, with conditions such as keloids and hypertrophic scarring, both involving tissue overgrowth in wound healing.

Are Peyronie’s disease sufferers prone to other related conditions?

About 30 percent of Peyronie’s disease sufferers also develop other systemic fibrosis in other connective tissue in the body. Common sites are the hands and feet. In Dupuytren’s contracture, scarring or thickening of the fibrosis tissue in the palm leads progressively to a permanent bending of the pinkie and ring fingers into the hand. While the fibrosis occurring in both diseases is similar, it is not clear yet what causes either plaque type or why men with Peyronie’s disease are more likely to develop Dupuytren’s contracture.

Will Peyronie’s disease evolve into cancer?

No. There are no documented cases of progression of Peyronie’s disease to malignancy. However, if your doctor observes other findings that are not typical with this disease—such as external bleeding, obstructed urination, prolonged severe penile pain—he or she may elect to perform a biopsy on the tissue for pathological examination.

What should men remember about Peyronie’s disease?

Peyronie’s disease is a well-recognized but poorly understood urological condition. Interventions need to be individualized to each patient, based on the timing and severity of the disease. The objective of any treatment should be on reducing pain, normalizing penile anatomy so that intercourse is comfortable and restoring erectile function in patients who suffer erectile dysfunction. Although surgical correction is ultimately successful in the majority of cases, the early acute phase of this disease is customarily treated by either oral and/or intralesional approaches. As medical researchers continue to develop basic and clinical research for a better understanding of this disease, more therapies and targets for intervention will become available.

  • Share/Bookmark

Sex therapy for erection problems

Sex therapy may be helpful for some men who have erection problems (erectile dysfunction). Sex therapy does not involve having sex with or in front of the sex therapist. It is also not long-term or open-ended therapy. It usually involves working with a therapist who recommends gradual steps to change sexual behavior.

Sex therapy helps you understand and accept that emotions (such as anxiety or sadness) can easily become associated with physical factors or reactions. It is based on the following premises:

  • Both partners share responsibility for helping solve the problem, even if it is due to physical causes.
  • You and your partner receive information and education about sexual techniques.
  • It is necessary to change any negative attitudes toward sex.
  • It is necessary to open up lines of communication between you and your partner.

Sex therapy may involve:

  • Talking about the multiple causes of sexual problems and how emotions can play a role in physical causes.
  • Using a variety of psychological tests.
  • Talking about the natural changes in sexual function that occur with aging.
  • Offering specific suggestions for enhancing sexual enjoyment (such as altering foreplay, using lubricants, getting enough rest, eliminating distractions).
  • Share/Bookmark